The 2019 APSAD Scientific Program Committee is pleased to announce the Pre-Conference Workshops to be held on Sunday 10 November 2019.

Places are limited, so make sure you sign up during your conference registration.

Already registered and forgot to add your workshop? Contact the conference secretariat at and we will add your chosen workshop to your registration.

More information on workshops given below:


  Workshop 1: Hepatitis C in Primary Care and Drug and Alcohol Settings
When: 8.30am – 4.30pm
Cost: Free for full conference registrants.
Non-delegates may attend but priority is given to conference attendees.
Presenters: TBC
Overview: TBC


 Workshop 2: Nicotine Addiction and Smoking Cessation Update Day
When: 9.30am – 5.00pm
Cost: Member Rate: AUD $60
Non-Member Rate: AUD $75
Overview: The traditional aim of the update day has been just that: to update tobacco treatment specialists in the current trends and research regarding clinical practice in smoking cessation. The ideal meeting participant would enhance their considerable previous knowledge and utilise knowledge gained at the update day to enhance their clinical practice. This differentiates the UPDATE DAY from other tobacco control meetings which may focus on policy, legislation and other non-clinical aspects


 Workshop 3: NCCRED Symposium
When: 1.00pm – 6.30pm
Cost: Free, Registration to be opened
Overview: The inaugural National Centre for Clinical Research on Emerging Drugs (NCCRED) symposium will be held on the 10th of November and will highlight the work of the Centre.
This event is free for all to attend and will include presentations from the successful grant applicants from Round 1.


 Workshop 4: Indivior Symposium: Expanding treatment options for opioid dependence
When: 5.00pm – 8.00pm
Cost: Free
Presenters: TBC
Overview: A new treatment option for opioid dependence is moving from research into clinical practice. This will be a practical review of data and early clinical experience focusing on patient management, patient experience and the future role of new and existing treatment options